There is a complex network of collagen throughout the heart. It is composed of a hierarchy of fibrils and fibers ranging from 10 nm to 2-3 microns in diameter. This network can be broken down by ischemia, adriamycin administration, or disulfide administration in laboratory animals. Following loss due to coronary artery ligation, the ischemic area begins bulging within 3 h. General loss of portions of the collagen matrix is induced by intravenous oxidizing glutathione, and results in marked diffuse ventricular dilatation. Generalized collagen loss in the ventricles, as induced by disulfide administration or adriamycin infusion, persists for 6 months at which time evidence of some replacement is visible, and evidence of diffuse fibrosis is present. In humans, cardiac dilatation occurs in a variety of disease states without overstretch of sarcomeres. This presumes rearrangement of the muscle bundles, which can only occur with marked alterations of the collagen matrix. Ventricular dilatation, associated with viral myocarditis or puerperal cardiomyopathy, may persist for months, suggesting the collagen loss, as with the experimental animals, takes many months to repair. The cardiac dilatation may ameliorate, or, in some patients, deteriorate into heart failure. The animal experiments with loss of the collagen matrix, ventricular dilatation, and failure to replace the matrix for many months provide an explanation for persistent cardiac dilatation in various human diseases.
INTRODUCTION
Blood pressure and forward flow of blood are derived from the interaction of actin and myosin in myocytes. The force generated in the sarcomeres requires a system for delivery to the ventricular cavity. Diastolic filling pressure in the ventricle must be delivered to the sarcomeres so that, at least in contiguous cells, sarcomere stretch is near equal. The marked pressure differences during the cardiac cycle as well as the reversal in force direction predicate a complex network to accomplish these results. Of the materials available in the heart, collagen has the necessary physical properties, especially when in a woven network, to accomplish force distribution (18) . There is a complex network of collagen throughout the heart that has been described using scanning electron microscopy (SEM) (6, 8, 30) . The hierarchy of fibers and fibrils has a broad range of sizes and for visualization requires light microscopy, scanning, and transmission electron microscopy (31) . The overall function offorce delivery and maintenance of cardiac geometry is conceptually simple. Assignment of specific functions to one or more ofthe components has not been accomplished in many cases.
Briefly, the collagen matrix at the level of SEM consists of a series of collagen bundles that interconnect myocytes ( Fig. 1) (8) . In rats, these insert just off the Z-line and seem to be in sufficient number to tether adjacent myocytes throughout the cardiac cycle. A similar set ofcollagen bundles connects capillaries to all contiguous myocytes (Fig. 2) . Insertion of both sets of collagen bundles is into the basal lamina of the capillaries and myocytes. These are arranged such that during systole, tension can be placed on the wall of the capillary and patency maintained in the presence of high tissue pressures (9, 21) . A weave-like network of collagen bundles that surrounds groups of myocytes appears to be associated with the elastic modulus of the ventricular wall (5) ( Fig. 3 ). Large coiled perimysial fibers are present, arranged in parallel with adjacent myocytes. These structures are more common in the 488 FIG. i.-Scanning electron micrograph (SEM) of normal rat heart demonstrating struts interconnecting myocytes (arrows) and a large coiled perimysial fiber (CM). The struts insert into the basal lamina. Bar = 51lm. x 9,600. papillary muscles and may account for the observation that papillary muscles are more stiff than the ventricular wall proper. To date, no specific structures have been identified that are the means by which force is delivered throughout the ventricle.
In general, collagen is thought to be reasonably non-reactive chemically under normal physiologic conditions. Collagen in the heart does turn over, but quite slowly; thus, the enzymes for synthesis and degradation are present in adult hearts (22, 28) . The major emphasis in this paper will be to demonstrate that the collagen matrix of the heart is quite labile under certain conditions and, when deficient, may affect cardiac geometry. Three basic experimental conditions, ischemia, adriamycin infusion, and disulfide infusion, all result in marked loss ofthe portions of the collagen matrix.
Loss OF THE COLLAGEN MATRIX Ischemia
Coronary ligation in dogs results in extensive loss of portions of the collagen matrix in about 3 hr (II, 33). This loss, as seen with SEM, is most complete near the center of the infarct, but does extend beyond the limits ofthe necrotic tissue to involve areas containing viable myocytes. Examination of the ischemic area at I and 2 hr reveals no detectable change in the collagen matrix; however, at 3 hr there is near complete loss in the center of the ischemic areas ( Fig. 4) . At the border of the infarct where viable cells are present, collagen loss is quite extensive ( Fig. 5 ). If one measures the strain rate in the infarcted region, it increases by 50% within minutes after occlusion and then maintains a plateau until about 2.5 hr postligation (10) . The strain rate increases to 200-300% at 3 hr postocclusion and then remains constant. This marked increase in strain rate coincides with the loss of collagen and suggests that the collagen is necessary to maintain normal geometry and that, in its absence, dilatation occurs. A recent paper indicates that with ischemia produced by coronary artery ligation, collagenases are activated (34) . The source of these enzymes is not clear, although collagenase was demonstrated in many tissues, including the heart, by fluorescent antibody techniques (27) .
Myocardium repeatedly made ischemic for brief periods by coronary artery occlusion, so-called "stunned myocardium," demonstrates marked loss of the collagen matrix (36) suggesting that the collagenolytic activity is derived from other than necrotic myocytes.
These 2 models ofischemia are clearly associated with activation of collagenolytic enzymes in the heart. Neither provides much evidence about the mechanism of activation and neither is of much value in studying replacement ofthe normal matrix. In the course of an infarct, fibroblasts are rapidly activated and replacement type fibrosis results (25) . This disposition of collagen in a scar following infarction bears no resemblance to the normal matrix. If one blocks the inflammatory reaction following an infarct with glucocorticoids, this will reduce the incidence of arrythmias, but the steroids also block collagen synthesis and the incidence of ventricular rupture becomes unacceptably high (29) .
Adriamycin
Adriamycin is cardiotoxic by at least 2 mechanisms. Large doses acutely suppress cardiac function and can result in heart failure and death (23) . There is also a long-term cardiotoxicity that may show up 6-24 months after cessation oftherapy (7, 19) . This chronic toxicity is associated with diffuse fibrosis of the heart and is markedly accentuated by x irradiation (17) . The latter, by itself, can initiate diffuse fibrosis. In order to better define the chronic toxicity with diffuse fibrosis, we infused 80 rats with a single . injection of 4.5 mg/kg or 6 mg/kg and sacrificed them weekly for 6 weeks, then 8, 12, and 16 weeks postinjection (12) . None of the animals died spontaneously, although all lost weight for about 2 weeks. Examination by SEM, I and 2 weeks postinfusion, indicated no discemable loss of the normal collagen matrix. However, at 2 weeks, evidence of collagen between myocytes in a highly abnormal distribution and size range was noted. The collagen appeared as dense condensations of fibrils with a marked degree of diameter variation. Examination at later dates indicated more of these aggregates with apparent fusion of many fibrils forming broad bands of collagen, as well as very narrow bands, with a distribution quite different from normal ( Fig. 6) .
At 3 and 4 weeks postadriamycin infusion, definite loss of the matrix is evident. This loss is most marked at 6 weeks and persists for the entire period of observation, 16 weeks ( Fig. 7) . Failure to replace the normal matrix while aggregates of collagen are being deposited suggests that fibroblasts are present and functional, but whatever causes extracellular organization of the collagen into the normal matrix is absent.
The hearts of 2 patients that died 30 and 35 days after cessation of adriamycin therapy were examined by SEM and in each, large areas of loss of the collagen matrix was evident ( Fig. 8 ). One patient died suddenly ofa pulmonary embolus and the other with sepsis. Neither case had premortem evidence of heart failure, but, at autopsy, each had a dilated heart.
Disulfides
A variety of disulfide reagents have been shown to activate neutrophile collagenase in vitro (35) . We perfused rat hearts on a Langendorff apparatus with 2 mm/liter oxidized glutathione (GSSG) or 5,5' Dithio-bis-(2 nitrobenzoic acid) (DTNB) in a modified Krebs-Hensleit buffer (12) . The hearts were initially flushed with 10 cc of Krebs-Hensleit buffer (K-H) with heparin to remove blood. Perfusion through the aorta at 80 cm H 2 0 pressure with the perfusate, gassed with 95% O 2 and 5% CO 2 , was carried out for 3 hr. On completion of the perfusion, the hearts were perfusion-fixed through the aorta at 80 em H 20 pressure with 2% glutaraldehyde in a phosphate buffer (13) . Tissue was obtained and processed for SEM and standard light microscopy. A total of 52 rat hearts were perfused, 44 with one or another of the disulfides and 8 controls, as well as 10 hearts examined immediately after removal from the animal with no perfusion by the Langendorff technique. With 3 hr of disulfide perfusion, the myocyte to myocyte struts, the collagen struts connecting capillaries to myocytes, and most ofthe weave complex were no longer visible ( Fig. 9) (13) . This loss is selective in that the subendocardial and subepicardial collagen complexes, and the collagen around larger arteries and veins appear to be quite normal with no evidence of breakdown. No loss is detectable with 2 hr of perfusion; however, if the heart is perfused for 1 hr with a disulfide and then 2 hr with Krebs-Hensleit solution alone, almost complete loss of the collagen complex occurs. These results indicate that the collagenolytic activity resides in the heart, not in the plasma, that activation occurs with I hr exposure to disulfides, and that there is no 5 min of starting a perfusion, DTNB is present in the urine. Unless the disulfides are very concentrated in heart tissue, the amount ofGSSG delivered to the heart is well below the concentrations ofGSSG produced by ischemic heart tissue, which have been measured at 50 J,Lmol/g heart (14, 32) . Sections of all hearts were examined by SEM and bright field and polarizing light microscopy. Two things are evident. Firstly, there is no evidence of myocyte damage with in vivo or in vitro disulfides at any time and secondly, most of the collagen matrix under consideration is not visible by light microscopy. The concentration and total amount of GSSG used appear to be near a concentration obtainable in ischemic hearts. The release of GSSG by ischemic heart tissue could result in loss of the collagen matrix.
Loss induced by 2 in vivo perfusions of GSSG or DTNB results in cardiac dilatation (Fig. 12 ).
Collagen Replacement
Replacement ofthe normal matrix followingadriamycin or disulfide infusion is extremely delayed, being visible 6 months following treatment, but areas of loss are prominent ( Fig. 13) (12) . This is in marked contradistinction to the normal process in neonatal rats. When rats are born, the collagen matrix, consisting of struts interconnecting adjacent DTNB 12 CONTROLĨ ! 1111IIIII! I11111111 visible myocyte damage by light microscopy, SEM, or transmission electron microscopy (13) .
A solution for cold organ preservation, developed at the University of Wisconsin (UW solution), contains reduced glutathione (GSH) in the fresh condition (3). However, 4 days after addition of the GSH, all of it spontaneously oxidizes to GSSG, resulting in a 2.4 mm/liter concentration (2) . In simulating organ preservation, we removed rat hearts, flushed them with 7-8 cc of aged UW solution, i.e., GSSG containing, and then perfused them in the cold with a "Sage" pump using 1-2 cc/hr for a maximum of about 14-15 cc or a total of 35 J,Lmol of GSSG. Following the cold perfusion, the hearts were placed on a Langendorffapparatus and perfused via the aorta at 35°C for 3 hr with K-H solution. After the perfusion, sections of the heart were prepared for SEM and light microscopy. The hearts perfused with GSH containing UW solution were essentially the same as control hearts perfused with the cold, high K+ (30 mM) K-H solution. The hearts perfused with aged UW solution, i.e., GSSG containing, showed marked loss of collagen by SEM (Fig. 10) .
These experiments indicate that disulfides activate collagenolytic enzymes that in all probability reside in the heart, not in the plasma. Since none of the hearts showed any evidence of myocyte damage, it is unlikely that the activity was released from the myocytes. Activation ofthe enzymatic complex was accomplished at 4°C, arguing against synthesis and supporting the notion that the collagenolytic enzymes are present in a non-active form.
Since the disulfides were active in vitro with no evidence of toxicity, we infused anesthetized rats with 2 or 3 mm/liter of DTNB or GSSG. The perfusion protocol was to infuse the solution via the femoral or jugular vein at 5-7 cc/hr for 3 hr with each rat getting 20-21 cc. At the completion of a single injection, no change in the SEM appearance could be appreciated and the total OH-proline was slightly, but not significantly, reduced from control values. Seventy-two hr postperfusion, the total OHproline was reduced by 25% and, by SEM, some areas ofthe matrix had disappeared. One week after the first perfusion, the animals were perfused a second time and examined one week later. At this time, the OH-proline was reduced to about 60% of control values and over the next 3 weeks it drifted down to about 50% of control values. By SEM, considerable loss of the collagen matrix had occurred within 1 week following the second perfusion (Fig. 11 ). The amount of GSSG perfused into the 250-300 g rats was 60 J,Lmol over 3 hr. Assuming a 7% blood volume, this would result in a maximum concentration of 6 J,Lmol/cc of plasma. The residence time of the GSSG and DTNB in tissue is unknown, but within myocytes and struts connecting capillaries to. contiguous myocytes, is not present. The weave IS not visible. Basically, the components absent are those analogous to the endomysium and perimysium of skeletal muscle. Four days post-natal, small sprouts of collagen are visible on the basement membranes of myocytes and capillaries. By 20 days, the adult appearance of the matrix occurs, although much growth still remains (4). Thus, loss. of t~e colla~en matrix in adult animals is not repaired 10 anything like the time needed for complete development in 'the newborn. The reason for this delay in replacing the normal matrix is not known.
The cardiac matrix contributes to maintenance of the normal geometry of the heart as evidenced by the bulging associated with an infarct and loss of the matrix. Following infusion of disulfide, on 2 occasions one week apart, the heart is easily dilated beyond normal limits, with measured left ventricular volumes 40-50% above controls (Fig. 12) .
Cardiac dilatation occurs with a variety of myocardial diseases including viral myocarditis, post-partum cardiomyopathy, adriamycin administration, and diffuse or global ischemia among others (15, 16, 20, 26) . Linzbach (24) pointed out that, in markedly dilated hearts, sarcomeres were not overstretched, but were of the same length as those in normal hearts. To accomplish dilatation, there has to be a rearrangement of the muscle bundles or myocytes. This can only be accomplished by a breakdown in the collagen matrix. The enzymes necessary are present and can be activated by at least one substance, GSSG, that is present in adequate concentrations in ischemic hearts, at least. Undoubtedly, there are other substances, especially disulfides, that might be present under some conditions in sufficient concentration to inaugurate collagenolysis. The dilatation that occurs with viral myocarditis or post-partum cardiomyopathy, in many cases, resolves promptly (4, 16, 20, 26) . However, in some cases, dilatation persists for months and may deteriorate to a dilated cardiomyopathy with heart failure (4, 16, 20, 26) . At autopsy, the predominant cardiac findings are large dilated chambers, which are flabby, and have diffuse fibrosis and only occasionally scars indicative of replacement fibrosis (I). Our present postulate for these cases is that some type of injury occurs, resulting in loss of portions of the collagen matrix and thus dilatation. Replacement of the normal matrix, as with the rat hearts following adriamycin or disulfide, requires months, during which time the heart remains dilated. In some cases, replacement of normal matrix occurs and the heart may decrease in size, whereas in other cases, diffuse fibrosis occurs which alters diastolic properties of the heart and eventually leads to heart failure.
